Huminig, Ayisha .
HRN: 27-31-84 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2026
CEFUROXIME 750MG (VIAL)
01/28/2026
02/04/2026
IV
470mg
Q 8 Hours
T/C Bacterial Infection
Checking Initial Appropriateness
01/28/2026
MUPIROCIN 2%, 15G (TUBE)
01/28/2026
02/04/2026
TOPICAL
As Needed
BID
T/C Bacterial Infection
Checking Initial Appropriateness